��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2006, 32(1) 26-29 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��м��
	��
	T�ܰ�ϸ��
	��
	��
	֣��
	PubMed
	Article by TIAN Han
	Article by ZHENG Jie

��м��߷��ӵ��

��, ֣��

�Ϻ��ڶ�ҽ�ƴ�ѧ��ҽԺƤ��, 200025

ժҪ��

��м��һ��ԡ��֢��Ƥ��Tϸ��Ⱥʧ�⡢��γ�ϸ��쳣��ֳ���ܰ�ϸ��Ƥ��ֲ��Ľ��һ��,��߷��ʽ��,��Ǳ��쳣��໥��õ��ߵ��ʧ�⡣ͨ��һ��ʽ,�໥�յ��ڡ��׿��ӻ�Эͬ,��м��Ӧ��֢��Ӧ�ķ��չ��ת�顣

�ؼ���� м�� T�ܰ�ϸ��

Psoriasis and the Regulation Network of Immune Molecules

Shanghai Ruijin Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200025, China

Abstract:

Psoriasis is a common, chronic inflammatory cutaneous disorder with bright red and scaly plaques. In the development of this disease, the disequilibrium of T cell subsets, the abnormal proliferation as well as activation of keratinocytes and the lymphocyte recruitment to the skin, immune molecules express abnormally and interact as a network, which may result in the imbalance of the immune regulation network and affect the immune response as well as the occurrence, development and outcome of the inflammatory response in psoriasis. This paper reviews how the complex biological system, including various immune molecules, functions in the pathogenesis of psoriasis.

Keywords: Psoriasis Immunity T-lymphocytes

�ո�� 2005-05-06 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Friedrich M,Krammig S,Henze M,ct al.Flow cytometric characterization of lesional T cells in psoriasis:intracellular cytokine and surface antigen expression indicates an activated,memory/effector type 1 immunophenotype.Arch Dermatol Res,2000,292:519-521.
[2] Ovigne JM,Baker BS,Brown DW,et al.Epidermal CD8⁺ T cells in chronic plaque psoriasis are Tcl cells producing heterogeneous levels of interferon-gamma.Exp Dermatol,2001,10:168-174.
[3] Szegedi A,Aleksza M,Gonda A,et al.Elevated rate of Thelperl (T(H) 1) lymphocytes and serum IFN-gamma levels in psoriatic patients.Immunol Lett,2003,86:277-280.
[4] Ghoreschi K,Rocken M.Immune deviation strategies in the therapy of psoriasis.Curr Drug Targets Inflamm Allergy,2004,3:193-198.
[5] Ghoreschi K,Thomas P,Breit S,et al.Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.Nat Med,2003,9:40-46.
[6] Kawamura A,Adachi K,Ishihara S,et al.Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma.Cancer,2001,91:339-345.
[7] Wittmann M,Purwar R,Hartmann C,et al.Human keratinocytes respond to interleukin-18:implication for the course of chronic inflammatory skin diseases.J Invest Dermatol,2005,124:1225-1233.
[8] Bozza M,Bliss JL,Dorner AJ,et al.Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4⁺ T cells.J Interferon Cytokine Res,2001,21:21-30.
[9] Albanesi C,Scarponi C,Cavani A,et al.Interleukin-17 is produced by both Th1 and Th2 lymphocytes,and modulates interferon-gamma-and interleukin-4-induced activation of human keratinocytes.J Invest Dermatol,2000,115:81-87.
[10] Trepicchio WL,Ozawa M,Walters IB,et al.Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.J Clin Invest,1999,104:1527-1537.
[11] Liao YC,Liang WG,Chen FW,et al.IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha.J Immunol,2002,169:4288-4297.
[12] Victor FC,Gottlieb AB.TNF-alpha and apoptosis:implications for the pathogenesis and treatment of psoriasis.J Drugs Dermatol,2002,1:264-275.
[13] Johansen C,Flindt E,Kragballe K,et al.Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.J Invest Dermatol,2005,124:1284-1292.
[14] Schon MP,Zollner TM,Boehncke WH.The molecular basis of lymphocyte recruitment to the skin:clues for pathogenesis and selective therapies of inflammatory disorders.J Invest Dermatol,2003,121:951-962.
[15] Hafezi-Moghadam A,Thomas KL,Prorock AJ,et al.L-selectin shedding regulates leukocyte recruitment.J Exp Med,2001,193:863-872.
[16] Singbartl K,Thatte J,Smith ML,et al.A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8⁺ lymphocyte rolling in inflamed venules.J Immunol,2001,166:7520-7526.
[17] Jiang WY,Chattedee AD,Raychaudhuri SP,et al.Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.Int J Dermatol,2001,40:699-703.
[18] Duan H,Koga T,Kohda F,et al.Interleukin-8-positive neutrophils in psoriasis.J Dermatol Sci,2001,26:119-124.
[19] Homey B,Dieu-Nosjean MC,Wiesenborn A,et al.Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.J Immunol,2000,164:6621.
[20] Kakinuma T,Saeki H,Tsunemi Y,et al.Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.J Allergy Clin Immunol,2003,111:592-597.
[21] Vestergaard C,Johansen C,Otkjaer K,et al.Tumor necrosis factoralpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.Cytokine,2005,29:49-55.